A pill camera that can take photos of the colon has received approval by the U.S. Food and Drug Administration on Feb. 3. Given Imaging created the pill, which has a global market of about 3 million procedures each year.
The pill, called the PillCam Colon, may be used for detection of colon polyps in patients after an incomplete optical colonoscopy, the Israeli medical device maker said.
There are 750,000 patients in the United States alone who experience an incomplete colonoscopy each year, Given Imaging said, and they often incur additional costs, along with the inconvenience and risk associated with other procedures to complete the colorectal examination.
Given Imaging is a developer of technology for visualizing, diagnosing and monitoring the digestive system, including its PillCam, a swallowed capsule endoscope.
In December, medical device maker Covidien PLC said it would acquire Given Imaging for $860 million. The transaction is expected to be completed by March 31.
According to the American Cancer Society, there will be about 96,830 new cases of colon cancer in the United States for 2014. There are fewer cases today than there was about 20 years ago because of early screening. In addition, treating colon cancer has also improved.
The camera pill can help help with early screening to detect colon cancer, which can save lives.